Filing Flows › ResMed (RMD) › Q1 FY27 › vs Q1 FY26
ResMed (RMD) Q1 FY27 vs Q1 FY26 (year over year)
ResMed's revenue rose $79.2M (+6%) from $1.3B in Q1 FY26 to $1.4B in Q1 FY27. The biggest changes: Total Sleep and Breathing Health +$90.4M (+8%); Residential Care Software −$11.1M (-7%). Gross margin 61.5% against 61.2% (+0.3 pts).
ResMed, Q1 FY27: revenue $1.4B (+6% year over year), operating margin 32.0%, net earnings $418M, operating cash flow $422M. The chart draws each line against Q1 FY26, the increases inside each band.
Margins
| Q1 FY27 | Q1 FY26 | Change | |
|---|---|---|---|
| Gross margin | 61.5% | 61.2% | +0.3 pts |
| Operating margin | 32.0% | 33.4% | -1.4 pts |
| Net margin | 29.6% | 26.1% | +3.5 pts |
| Free cash flow margin | 26.4% | 31.0% | -4.6 pts |
Every line
| Line | Q1 FY27 | Q1 FY26 | Change | % |
|---|---|---|---|---|
| Total Sleep and Breathing Health | $1.3B | $1.2B | $90.4M | +8% |
| Residential Care Software | $155M | $166M | −$11.1M | -7% |
| Revenue | $1.4B | $1.3B | $79.2M | +6% |
| Gross profit | $871M | $818M | $52.9M | +6% |
| Cost of revenue | $544M | $518M | $26.3M | +5% |
| Other income, net | $86.2M | $256K | $85.9M | 337× |
| Operating profit | $453M | $447M | $6.4M | +1% |
| Operating expenses | $418M | $371M | $46.5M | +13% |
| Pre-tax earnings | $539M | $447M | $92.4M | +21% |
| Research & development | $103M | $89.5M | $13.4M | +15% |
| SG&A | $315M | $282M | $33.1M | +12% |
| Net earnings | $418M | $349M | $69.9M | +20% |
| Income tax | $121M | $98.3M | $22.5M | +23% |
| Depreciation & amortization | $41.7M | $47.7M | −$6.0M | -12% |
| Share-based compensation | $29.5M | $21.2M | $8.3M | +39% |
| Working capital & other | $67.2M | −$39.9M | $107M | — |
| Operating cash flow | $422M | $457M | −$34.9M | -8% |
| Free cash flow (OCF − capex) | $374M | $414M | −$40.7M | -10% |
| Capital expenditures | $48.7M | $43.0M | $5.8M | +13% |
Questions
How much did ResMed's revenue grow year over year in Q1 FY27?
ResMed's revenue rose $79.2M (+6%) from $1.3B in Q1 FY26 to $1.4B in Q1 FY27.
What drove ResMed's revenue change in Q1 FY27?
Total Sleep and Breathing Health +$90.4M (+8%); Residential Care Software −$11.1M (-7%).